The predictive value of relative wall thickness on the prognosis of the patients with ST-segment elevation myocardial infarction

相对壁厚对ST段抬高型心肌梗死患者预后的预测价值

阅读:2

Abstract

OBJECTIVE: The study aimed to evaluate the prognostic value of relative wall thickness (RWT) in the patients with ST-segment elevation myocardial infarction (STEMI). METHODS: A total of 866 patients with STEMI admitted in Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School from November 2010 to December 2018 were enrolled in the current study retrospectively. Three methods were used to calculate RWT: RWT(PW), RWT(IVS+PW) and RWT(IVS). The included patients were divided according to the median values of RWT(PW), RWT(IVS+PW), and RWT(IVS), respectively. Survival analysis were performed with Kaplan-Meier plot and multivariate Cox proportional hazard model was established to evaluate the adjusted hazard ratio of the three kinds of RWT for all cause death, cardiac death and MACE (major adverse cardiac death). RESULTS: There was no significance for the survival analysis between the low and high groups of RWT(PW), RWT(IVS+PW) and RWT(IVS) at 30 days and 12 months. Nonetheless, the cumulative incidence of all cause death and cardiac death in the low group of RWT(PW) and RWT(IVS+PW) was higher than those in the high group at 60 months. The cumulative incidence of MACE in the low group of RWT(PW) was higher than the high group at 60 months. Multivariate Cox regression model showed that RWT(PW) were inversely associated with long-term cardiac death and MACE in STEMI patients. In the subgroup analysis, three calculations of RWT had no predictive value for the patients with anterior myocardial infarction. By contrast, RWT(PW) was the most stable independent predictor for the long-term outcomes of the patients with non-anterior myocardial infarction. CONCLUSION: RWT(PW), RWT(IVS+PW) and RWT(IVS) had no predictive value for the long-term clinical outcomes of patients with anterior myocardial infarction, whereas RWT(PW) was a reliable predictor for all cause death, cardiac death and MACE in patients with non-anterior myocardial infarction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。